These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8952287)

  • 21. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.
    Olesen J
    Cephalalgia; 1997 Aug; 17(5):559. PubMed ID: 9251869
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine revolution and sumatriptan.
    Palmer JB; Salonen R
    Lancet; 2000 Jun; 355(9222):2250-1. PubMed ID: 10881915
    [No Abstract]   [Full Text] [Related]  

  • 25. Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study.
    Farmer K; Cady R; Bleiberg J; Reeves D; Putnam G; O'Quinn S; Batenhorst A
    Headache; 2001 Apr; 41(4):377-84. PubMed ID: 11318884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eletriptan: pharmacological differences and clinical results.
    Giffin N
    Curr Med Res Opin; 2001; 17 Suppl 1():s59-62. PubMed ID: 12463280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Migraine: sumatriptan].
    Yamada K; Naritomi H
    Nihon Naika Gakkai Zasshi; 2001 Apr; 90(4):607-12. PubMed ID: 11391907
    [No Abstract]   [Full Text] [Related]  

  • 29. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 27-year-old woman with migraine headaches, 1 year later.
    Daley J; Delbanco TL; Hartman EE
    JAMA; 1998 Mar; 279(12):954. PubMed ID: 9544771
    [No Abstract]   [Full Text] [Related]  

  • 31. New insights into the molecular actions of serotonergic antimigraine drugs.
    Durham PL; Russo AF
    Pharmacol Ther; 2002; 94(1-2):77-92. PubMed ID: 12191595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain stem activation in spontaneous human migraine attacks.
    Weiller C; May A; Limmroth V; Jüptner M; Kaube H; Schayck RV; Coenen HH; Diener HC
    Nat Med; 1995 Jul; 1(7):658-60. PubMed ID: 7585147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

  • 34. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine.
    Tfelt-Hansen P; Henry P; Mulder LJ; Scheldewaert RG; Schoenen J; Chazot G
    Lancet; 1995 Oct; 346(8980):923-6. PubMed ID: 7564725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
    Mathew NT; Kailasam J; Gentry P; Chernyshev O
    Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M; Faulds D
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Issues relating to the assessment of migraine recurrence following triptan therapy.
    Millson D; Tepper S
    Eur J Neurol; 1999 Jul; 6(4):525-6. PubMed ID: 10362912
    [No Abstract]   [Full Text] [Related]  

  • 38. The name of a drug used for the treatment of migraine.
    Mattsson P
    Eur J Public Health; 2002 Jun; 12(2):155. PubMed ID: 12073756
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects.
    Boska MD; Welch KM; Schultz L; Nelson J
    Cephalalgia; 2000 Feb; 20(1):39-44. PubMed ID: 10817445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies.
    Winner P; Mannix LK; Putnam DG; McNeal S; Kwong J; O'Quinn S; Richardson MS
    Mayo Clin Proc; 2003 Oct; 78(10):1214-22. PubMed ID: 14531480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.